First Derivatives logo

FDP - First Derivatives News Story

2510p 0.0  0.0%

Last Trade - 8:46am

Market Cap £669.9m
Enterprise Value £753.0m
Revenue £228.5m
Position in Universe 489th / 1845

First Derivatives - Notice of Results

Tue 8th October, 2019 7:00am
RNS Number : 9869O
First Derivatives PLC
08 October 2019

8 October 2019


First Derivatives plc

("FD" or the "Group")


Notice of Results


FD (AIM: FDP.L, ESM: FDP.I) will announce its interim results for the six months ended 31 August 2019 on 5 November 2019.


The management team will host a briefing for analysts on the day at 9.30am at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD.




For further information please contact:


First Derivatives plc

Seamus Keating, Executive Chairman

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242



Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970



Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin


+353 1 667 0420




FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

Niamh Fogarty


+44 (0)20 3727 1000



About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.


For further information, please visit and

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.